Sensus Healthcare (SRTS)

• Market cap: $114M
• 1 day: 1.90%
• 5 days: 3.11%
• 1 month: 1.46%
• 3 months: 4.03%
• 6 months: 8.06%
• Year to date: -1.83%
• 1 year: 162.03%
• 5 years: 64.39%
• 10 years: 19.15%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Employees: 35

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1,121% more call options, than puts

Call options by funds: $171K | Put options by funds: $14K

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

27% more capital invested

Capital invested by funds: $17.7M [Q2] → $22.6M (+$4.85M) [Q3]

6% more funds holding

Funds holding: 47 [Q2] → 50 (+3) [Q3]

3.51% more ownership

Funds ownership: 20.19% [Q2] → 23.71% (+3.51%) [Q3]

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $11 58% upside
• Avg. target: $12.50 79% upside
• High target: $14 101% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen 38% 1-year accuracy 59 / 156 met price target	58% upside $11	Buy Maintained	18 Nov 2024
Maxim Group Anthony Vendetti 29% 1-year accuracy 4 / 14 met price target	101% upside $14	Buy Maintained	15 Nov 2024